Xiansheng Pharmaceutical Company Report issue

For profit Phase 2 Phase 3
Founded: Hainan China (1993)
Status: No NME R&D (1993)

Organization Overview

First Clinical Trial
2008
NCT00842491
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Jiangsu Xiansheng Pharmaceutical Co., | Jiangsu Xiansheng Pharmaceutical Co., LTD

Active Ingredients

Drugs in Phase 3 Trials (1)

ssd8432 (3 trials)

Drugs in Phase 2 Trials (4)

capecitabine (xeloda) (1 trial)

cisplatin (platinol) (1 trial)

endostatin (endostar) (1 trial)

ritonavir (Norvir) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Stomach Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 4
  • # of Trial APIs: 5